| 2024-04 |
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease |
European Journal of Gastroenterology and Hepatology
|
| 2024-02 |
Mobile App-Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial |
Journal of medical Internet research
|
| 2023-12 |
Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization |
Gut Microbes
|
| 2023-11 |
Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma |
Cell Communication and Signaling
|
| 2023-11 |
Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH |
Digestive and Liver Disease
|
| 2023-11 |
The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea |
Yonsei Medical Journal
|
| 2023-11 |
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis |
Alimentary Pharmacology and Therapeutics
|
| 2023-10 |
Utility of fusion imaging for the evaluation of ultrasound quality in hepatocellular carcinoma surveillance |
ULTRASONOGRAPHY
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-09 |
Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis |
The Korean Journal of Gastroenterology
|
| 2023-09 |
Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis |
Digestive and Liver Disease
|
| 2023-09 |
침술과 C형간염 바이러스 전파 위험성: 체계적 문헌 고찰 및 메타분석 |
The Korean Journal of Gastroenterology
|
| 2023-08 |
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
How can we improve surveillance system for alcohol-associated hepatocellular carcinoma? |
Journal of Gastroenterology and Hepatology (Australia)
|
| 2023-08 |
Advanced liver fibrosis predicts heart failure and hospitalizations in people with type 2 diabetes: A prospective cohort study from Hong Kong Diabetes Register |
Diabetes Research and Clinical Practice
|
| 2023-08 |
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B |
Liver international : official journal of the International Association for the Study of the Liver
|
| 2023-08 |
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis |
Clinical Gastroenterology and Hepatology
|
| 2023-05 |
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease |
Gut and Liver
|
| 2023-04 |
Successful Recovery After Veno-Arterio-Venous Extracorporeal Membrane Oxygenation Immediately Before Liver Transplantation in Multi-Organ Failure Including Acute Respiratory Distress Syndrome: A Case Report |
Transplantation Proceedings
|
| 2023-03 |
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease |
Liver International
|
| 2023-02 |
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma |
European Journal of Gastroenterology and Hepatology
|
| 2023-01 |
The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA |
Journal of Gastroenterology and Hepatology
|
| 2023-01 |
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis |
DIAGNOSTICS
|
| 2023-01 |
Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma |
Frontiers in Endocrinology
|
| 2023-01 |
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping |
Nature Communications
|
| 2022-12 |
Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors |
Yonsei Medical Journal
|
| 2022-10 |
Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma |
Liver International
|
| 2022-09 |
Gut microbial community differentially characterizes patients with nonalcoholic fatty liver disease |
Journal of Gastroenterology and Hepatology
|
| 2022-08 |
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model |
Gastroenterology Report
|
| 2022-07 |
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases |
Clinical and Molecular Hepatology
|
| 2022-07 |
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B |
Digestive Diseases and Sciences
|
| 2022-07 |
Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia |
Cancers
|
| 2022-06 |
Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS) |
Cancers
|
| 2022-06 |
Total Lesion Glycolysis on F-18-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on Y-90 PET/CT in Patients With Hepatocellular Carcinoma Treated With Y-90 Transarterial Radioembolization |
Clinical Nuclear Medicine
|
| 2022-04 |
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria |
Frontiers in Medicine
|
| 2022-04 |
Cost-effectiveness of chronic hepatitis C screening and treatment |
Clinical and molecular hepatology
|
| 2022-04 |
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-04 |
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study |
JOURNAL OF VIRAL HEPATITIS
|
| 2022-03 |
Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis |
JHEP REPORTS
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-02 |
Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells |
Cancers
|
| 2022-02 |
Predictors of Sarcopenia in an Obese Asian Population |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
|
| 2022-02 |
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study |
Cancers
|
| 2022-02 |
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA ,2,000 IU/mL |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2022-01 |
Metabolic Dysfunction–Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study |
Clinical and Translational Gastroenterology
|
| 2022-01 |
Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-01 |
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization |
Cancers
|
| 2021-12 |
Secular trend of treatment uptake in patients with chronic hepatitis B: A territory-wide study of 135 395 patients from 2000 to 2017 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-12 |
Novel liver stiffness-based nomogram for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection initiating antiviral therapy |
Cancers
|
| 2021-11 |
No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-11 |
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation |
HEPATOLOGY
|
| 2021-10 |
Current role of systemic therapy in transarterial chemotherapy-refractory hepatocellular carcinoma patients |
International Journal of Gastrointestinal Intervention
|
| 2021-10 |
Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2021-10 |
Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease |
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
|
| 2021-10 |
Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B |
HEPATOLOGY INTERNATIONAL
|
| 2021-09 |
Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-09 |
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
Cancers
|
| 2021-09 |
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-08 |
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy |
HEPATOLOGY INTERNATIONAL
|
| 2021-07 |
Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B |
Clinical and molecular hepatology
|
| 2021-07 |
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease |
Clinical and molecular hepatology
|
| 2021-06 |
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study |
Journal of Hepatocellular Carcinoma
|
| 2021-06 |
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-06 |
Metabolic activity assessment by <sup>18</sup>F-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-06 |
External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-05 |
Hepatitis B Core-Related Antigen: From Virology to Clinical Application |
SEMINARS IN LIVER DISEASE
|
| 2021-05 |
Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C |
GUT AND LIVER
|
| 2021-05 |
Combination therapy with anti‐T‐cell immunoglobulin and mucin‐domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-05 |
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B |
Journal of Hepatocellular Carcinoma
|
| 2021-04 |
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2021-04 |
Roadmap to resuming care for liver diseases after coronavirus disease-2019 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-04 |
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B |
Clinical and molecular hepatology
|
| 2021-04 |
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B |
HEPATOLOGY RESEARCH
|
| 2021-03 |
Artificial intelligence in liver disease |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-03 |
A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer |
Journal of liver cancer (대한간암학회지)
|
| 2021-02 |
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization |
Current Oncology
|
| 2021-02 |
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-01 |
High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma |
SCIENTIFIC REPORTS
|
| 2021-01 |
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2021-01 |
Hepatitis B Virus Cure: Targets and Future Therapies |
International Journal of Molecular Sciences
|
| 2021-01 |
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study |
DIGESTIVE DISEASES AND SCIENCES
|
| 2021-01 |
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy |
GUT AND LIVER
|
| 2021-01 |
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-12 |
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy |
JOURNAL OF VIRAL HEPATITIS
|